XML 30 R113.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SEGMENT INFORMATION Segment Assets (Details) - USD ($)
$ in Millions
12 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Oct. 31, 2017
Nov. 01, 2018
Segment Reporting Information [Line Items]        
Segment Reporting Reconciliation Item Assets $ 7,153 $ 5,690    
Cash and cash equivalents 1,382 2,247    
Prepaid expenses 94 80    
Investments 102 68    
Long term and other receivables 100 102    
Other 621 354    
Total assets 9,452 8,541   $ 8,558
Capital expenditures 155 177 $ 176  
Life Sciences and Applied Markets        
Segment Reporting Information [Line Items]        
Total assets 3,202 1,744    
Capital expenditures 59 47    
Diagnostics and Genomics        
Segment Reporting Information [Line Items]        
Total assets 2,620 2,679    
Capital expenditures 48 92    
Agilent CrossLab        
Segment Reporting Information [Line Items]        
Total assets 1,331 1,267    
Capital expenditures 48 38    
Segment Total [Member]        
Segment Reporting Information [Line Items]        
Total assets 7,153 5,690    
Capital expenditures $ 155 $ 177